Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2026-02-22 @ 8:32 PM
Study NCT ID:
NCT02175693
Status:
COMPLETED
Last Update Posted:
2020-01-09
First Post:
2014-06-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition and Safety in Patients With Cervical Dystonia
Sponsor:
Eisai Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04-02
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2014-06-24
First Submit QC Date:
None
Study First Post Date:
2014-06-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-07
Last Update Post Date:
2020-01-09
Last Update Post Date Type:
ACTUAL